Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Christina Elliott
Newcastle Authors
Title
Year
Full text
Dr Christina Elliott
Joshua Jackson
Dr Clive Ballard
Dr Dag Aarsland
Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment
2025
Dr Christina Elliott
Targeting the amyloid precursor protein interactome in Wnt signalling provides novel therapeutic strategies for Alzheimer's disease
2025
Dr Christina Elliott
Dr Dag Aarsland
Transcription-Driven Repurposing of Cardiotonic Steroids for Lithium Treatment of Severe Depression
2025
Dr Christina Elliott
Being Neurodivergent in Academia: How we stepped up to support others
2024
Dr Christina Elliott
Do thyroid hormones determine the neurotoxicity of cadmium?
2024
Dr Christina Elliott
PDE4B Missense Variant Increases Susceptibility to Post-Traumatic Stress Disorder-Relevant Phenotypes in Mice
2024
Dr Christina Elliott
Technology-enhanced learning in Pharmacology through non-linear storytelling
2024
Dr Christina Elliott
Dr Clive Ballard
Dr Dag Aarsland
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
2023
Dr Christina Elliott
Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release
2020
Dr Christina Elliott
A role for APP in Wnt signalling links synapse loss with β-amyloid production
2018
Dr Christina Elliott
Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil
2018
Dr Christina Elliott
FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system
2018
Dr Christina Elliott
Modelling and Mathematical Analysis of the M2-Receptor Dependent Joint Signaling and Secondary Messenger Network in CHO Cells
2018
Dr Christina Elliott
Plasma REST: a novel candidate biomarker of Alzheimer’s disease is modified by psychological intervention in an at risk population
2017
Dr Christina Elliott
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
2016
1
2